Editas Medicine, Inc.

EDIT · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
191
SEC Filings

Business Summary

PART I We are a pioneering gene editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The promise of genomic medicines is supported by the advancing knowledge of the human genome and by harnessing the progress in technologies for cell therapy, gene therapy, and, most recently, gene editing. We believe this progress sets the stage for us to create medicines with the potential to have a durable benefit for patients. Our cor...

Next Earnings

Q2 FY2026 — expected 2026-09-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionEDITdiscussed_in_filing Cybersecurity
topic_mentionEDITdiscussed_in_filing Trusted Computing
topic_mentionEDITdiscussed_in_filing Blockchain & Crypto
topic_mentionEDITdiscussed_in_filing Regulation
topic_mentionEDITdiscussed_in_filing Healthcare & Bio
topic_mentionEDITdiscussed_in_filing Platform & Ecosystem
topic_mentionEDITdiscussed_in_filing Cybersecurity
topic_mentionEDITdiscussed_in_filing Trusted Computing
topic_mentionEDITdiscussed_in_filing Blockchain & Crypto
topic_mentionEDITdiscussed_in_filing Regulation
topic_mentionEDITdiscussed_in_filing Healthcare & Bio
topic_mentionEDITdiscussed_in_filing Platform & Ecosystem
topic_mentionEDITdiscussed_in_filing Cybersecurity
topic_mentionEDITdiscussed_in_filing Trusted Computing
topic_mentionEDITdiscussed_in_filing Blockchain & Crypto
topic_mentionEDITdiscussed_in_filing Regulation
topic_mentionEDITdiscussed_in_filing Healthcare & Bio
topic_mentionEDITdiscussed_in_filing Platform & Ecosystem
topic_mentionEDITdiscussed_in_filing Cybersecurity
topic_mentionEDITdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001650664-26-000017EDGAR112K words
2025-03-052024-12-310001650664-25-000022EDGAR—
2024-02-282023-12-310001650664-24-000008EDGAR—
2023-02-222022-12-310001558370-23-001764EDGAR—
2022-02-242021-12-310001558370-22-001950EDGAR—
2021-02-262020-12-310001558370-21-001915EDGAR—
2020-02-262019-12-310001558370-20-001476EDGAR—
2019-03-012018-12-310001558370-19-001364EDGAR—
2018-03-082017-12-310001558370-18-001721EDGAR—
2017-03-032016-12-310001558370-17-001340EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001650664-25-000156EDGAR21K words
2025-08-122025-06-300001650664-25-000125EDGAR—
2025-05-122025-03-310001650664-25-000073EDGAR—
2024-11-042024-09-300001650664-24-000121EDGAR—
2024-08-072024-06-300001650664-24-000097EDGAR—
2024-05-082024-03-310001650664-24-000037EDGAR—
2023-11-032023-09-300001650664-23-000017EDGAR—
2023-08-022023-06-300001558370-23-012936EDGAR—
2023-05-052023-03-310001558370-23-008308EDGAR—
2022-11-022022-09-300001558370-22-016012EDGAR—
2022-08-032022-06-300001558370-22-011904EDGAR—
2022-05-042022-03-310001558370-22-007066EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001650664-26-000027EDGAR1K words
2026-03-090001650664-26-000013EDGAR—
2025-11-100001650664-25-000153EDGAR—
2025-10-090001650664-25-000148EDGAR—
2025-09-020001650664-25-000134EDGAR—
2025-08-120001650664-25-000123EDGAR—
2025-06-120001650664-25-000106EDGAR—
2025-06-020001650664-25-000086EDGAR—
2025-05-140001650664-25-000081EDGAR—
2025-05-130001650664-25-000077EDGAR—

191 total filings indexed. 159 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001650664
TickerEDIT
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 582da19fab5572740a0f9d7a01b7082ae59aea1dc5f95f127553933f3ba2cee5
parent: af838cb5263d6fff04145434b9a824d7228c87b7e64f6be9956a2995f219c9e2
content hash: 6f85c4fd36487de7be5ab87b2782662bca96f85508376828be9e05183d0cecd4
signed: 2026-04-13T04:44:47.309Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf